FDA approves and authorises updated mRNA COVID-19 vaccines
The mRNA COVID-19 vaccines have been updated with a monovalent component that corresponds to the Omicron variant KP.2 strain…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
FDA asks COVID vaccine makers to target KP.2 strain
Instead of the JN.1, the U.S. health regulator asks the manufacturers to update the new shots to target the KP.2 variant
Regional variations uncovered in the impact of dexamethasone treatment for severe COVID-19: Study
This study was conducted in Europe and India to examine the effects of giving patients injectable 12 mg versus 6 mg of…
MHRA approves Pfizer/BioNTech’s adapted COVID-19 vaccine for Omicron XBB.1.5
The vaccine has been approved for use in individuals from six months of age
High levels of exposure to COVID virus may reduce protection from vaccination, prior infection:…
The study was performed to understand whether the immunity gained after vaccination or a prior infection was less effective or…
Biden administration to urge Americans get COVID-19 boosters
The official said that while the Centers for Disease Control and Prevention are reporting an increase in infections and hospital…
OCTAVE study reveals vaccine response in patients with impaired immune systems
Preliminary data from the OCTAVE study in August 2021 showed that a significant proportion of clinically at-risk patients with…
SII restarts manufacturing of COVISHIELD
Adar Poonawalla informs that the company already has six million booster doses of Covovax vaccine available and adults must take…
Study finds air pollution lowers Covid vaccine response
The results show that in uninfected individuals, pre-pandemic exposure to PM2.5, NO2 and black carbon was associated with a 5 to…
China approves its first mRNA vaccine from CSPC
The company said its independently developed mRNA vaccine SYS6006 targets some major Omicron variants and its booster dose showed…
IIT Madras researchers develop database on coronavirus antibodies
‘Ab-CoV’ can be a vital resource for researchers to develop therapeutic strategies against new variants of coronaviruses by…
SARS-CoV-2 Omicron XBB.1.5 variant is highly transmissible and infectious: Study
The XBB.1.5 S protein was also found to be highly resistant to neutralisation antibodies elicited by breakthrough infection with…
Chinese regulators focus on homegrown COVID-19 therapies to tackle new variants: GlobalData
There are currently 16 COVID-19 drugs in clinical development in China, five of which are in Phase III. Most of these drugs in the…
US govt to procure 1.5 million more doses of Novavax COVID-19 vaccine
The protein-based vaccine was expected to convince those sceptical of the new mRNA-based vaccines against the virus from rivals…
Paxlovid decreased hospitalisation, risk of death during Omicron wave: Research
The research, published in the Canadian Medical Association Journal, aimed to evaluate the effectiveness of paxlovid, a…
Covid vaccines do not increase risk of adverse events: Study
The study is currently the only one in the world that monitored the population for more than a year, taking into account numerous…
Health minister unveils India’s first intra-nasal COVID vaccine
iNNCOVACC is the world’s first intra-nasal COVID-19 vaccine to receive approval for the primary two-dose schedule, and as a…
Sinopharm unit gets OK for clinical trials of mRNA COVID vaccine
The unit, based in the commercial hub of Shanghai, has built a research and development platform, as well as work